Manhattan Associates jumps as analyst upgrade highlights cloud momentum and AI traction
Investivoq PriceTracker
Manhattan Associates (MANH) is up 5.4% today. Here is some analysis on what might have caused this price movement.
Analysis: The move appears to be driven mainly by a bullish analyst upgrade that pointed to faster cloud bookings, a more favorable setup for revenue growth, and early traction for the company’s AI-focused products. Recent company results likely reinforced that view after Manhattan posted solid second-quarter growth and maintained a constructive 2026 outlook.
Details:
Sources:
Manhattan Associates Investor Relations, SEC, Investing.com
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$MANH Insider Trading Activity
$MANH insiders have traded $MANH stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $MANH stock by insiders over the last 6 months:
- JAMES STEWART GANTT (EVP, Professional Services) has made 0 purchases and 2 sales selling 12,439 shares for an estimated $2,021,355.
- ERIC ANDREW CLARK (President & CEO) has made 0 purchases and 2 sales selling 4,000 shares for an estimated $740,050.
- LINDA T. HOLLEMBAEK sold 1,579 shares for an estimated $299,820
To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.
$MANH Hedge Fund Activity
We have seen 234 institutional investors add shares of $MANH stock to their portfolio, and 272 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,677,333 shares (+97.9%) to their portfolio in Q2 2026, for an estimated $233,568,620
- ALLIANCEBERNSTEIN L.P. removed 817,133 shares (-26.2%) from their portfolio in Q2 2026, for an estimated $113,785,770
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 458,825 shares (+inf%) to their portfolio in Q2 2026, for an estimated $63,891,381
- JPMORGAN CHASE & CO added 454,668 shares (+inf%) to their portfolio in Q2 2026, for an estimated $63,312,519
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 416,291 shares (+76.2%) to their portfolio in Q2 2026, for an estimated $57,968,521
- ROYAL BANK OF CANADA removed 356,378 shares (-63.2%) from their portfolio in Q2 2026, for an estimated $49,625,636
- ROYCE & ASSOCIATES LP added 314,304 shares (+inf%) to their portfolio in Q2 2026, for an estimated $43,766,832
To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.
$MANH Government Contracts
We have seen $28,886,565 of award payments to $MANH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- ISSUE TASK ORDER AGAINST FOR LOGISTICS SUPPLY CHAIN MANAGEMENT SYSTEM CLOUD (LSCMS-C): $26,194,985
- CONTRACTOR SHALL PROVIDE PROFESSIONAL TECHNICAL EXPERTISE AND PROJECT MANAGEMENT SERVICES TO SUPPORT FOR TY...: $29,500
To track government contracts to publicy traded companies, check out Investivoq's government contracts dashboard. You can access data on government contracts through the Investivoq API government contracts endpoint.
$MANH Price Targets
Multiple analysts have issued price targets for $MANH recently. We have seen 5 analysts offer price targets for $MANH in the last 6 months, with a median target of $200.0.
Here are some recent targets:
- Guy Hardwick from Barclays set a target price of $201.0 on 05/29/2026
- Clark Wright from DA Davidson set a target price of $200.0 on 05/20/2026
- Joe Vruwink from Baird set a target price of $186.0 on 04/22/2026
- Parker Lane from Stifel set a target price of $200.0 on 04/22/2026
- George Kurosawa from Citigroup set a target price of $177.0 on 04/22/2026
This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.